Molecular Pharming Market Size is valued at USD 457.7 Mn in 2023 and is predicted to reach USD 1,299.8 Mn by the year 2031 at a 15.3% CAGR during the forecast period for 2024-2031.
In a biotechnological program known as "molecular farming," crops are genetically altered to create proteins and chemicals for industrial and pharmaceutical uses. The vast majority of developing nations cannot pay the enormous price of medical treatments brought on by the already-used techniques. Farmers are urged by mounting environmental concerns to reorient their efforts toward sustainable agriculture methods, including resource conservation. This has increased the demand for better crop nutrition and protection, supporting market expansion.
The molecular farming market growth is also anticipated to continue growing due to the rising demand for modern medicines and pharmaceuticals. Increasing environmental concerns are pressuring farmers to refocus their efforts on sustainable agriculture practices, including resource conservation. As a result, there is a tremendous need for improved crop nutrition and protection, which has helped the molecular farming industry to grow.
Competitive Landscape:
Some of The Molecular Pharming Market Players Are:
- Leaf Expression Systems
- ORF Genetics hf.
- Agrenvec S.L.
- PlantForm
- Protalix Biotherapeutics
- Kbio, Inc.
- Cape Biologix Technologies (Cape Bio Pharms)
- Bright Biotech
- Moolec Science SA
- Miruku
- Tiamat Sciences Corp.
- IngredientWerks
- Core Biogenesis
- Diamante Società Benefit S.r.l.
- Elo Life Systems
- G+FLAS Life Sciences, Inc.
- BIOBETTER
- MOZZA FOODS
- FORTE PROTEIN INC.
- KYOMEI
- NOBELL FOODS
- PIGMENTUM
- MNPHARM
- Finally Foods
- Tiamat Sciences
- POLOPO Ltd.
- VELOZBIO
- newmoo Foods
- BionFarming GmbH
Market Segmentation:
The molecular pharming market is segmented on the crop type, technology, applications and end users. The market is segmented based on crop type: maize, barley, tobacco, safflower, rice and alfalfa. Based on technology, the molecular pharming market is segmented into gene guns, agroinfiltration, electroporation, agrobacterium-mediated gene transfer and Others. Based on the application, the molecular pharming market is segmented into recombinant antibodies, hormones, vaccines, industrial enzymes, proteins & protein-based materials, technical reagents, and nutritional products. Based on end-use, the molecular pharming market is segmented into biotechnology & pharmaceutical companies, contract manufacturing organizations, and others.
Based On Technology, The Gene Gun Segment Is A Major Contributor To The Molecular Pharming Market
The market's leading segment is gene guns. A gene gun is a tool that is used to transport external (exogenous) DNA, RNA, or proteins to the cells in a way that allows the biological particles to be reproduced or translated using the plant reproduction system and to multiply the necessary biologics without the need of low-cost microbial systems.
The process known as agroinfiltration combines plant biotechnology and agriculture. To mass-create the desired protein, the approach simultaneously stimulates transitory gene expression in a plant, part of a plant, or numerous plants. A microbiological technique called electroporation, also referred to as electro-permeabilization, employs an electric field to make cells more permeable via their membranes. When utilized in plant biotechnology, these cells are preferably plant cells.
The Biotechnology & Pharmaceutical Companies Segment Witnessed Growth At A Rapid Rate
Biotechnology & pharmaceutical companies grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. Strong government support for the market is demonstrated by programs aiming to modernize the regulatory environment, enhance approval procedures and reimbursement practices, and standardize clinical studies. Biotechnological methods are expanding significantly, with examples including genetic engineering, DNA fingerprinting, and stem cell technologies.
The North American Molecular Pharming Market Holds A Significant Regional Revenue Share
The North American molecular pharming market is expected to register the highest market share in revenue shortly. The region's market has a high revenue due to factors including expanding government efforts that boost the implementation of modern agriculture technologies and established infrastructure. Additionally, a robust administrative framework helps farmers acquire the necessary skills for using and maintaining molecular farming equipment.
In addition, Asia Pacific is projected to grow rapidly in the global molecular pharming market. In emerging nations like India, Sri Lanka, and Nigeria, various government programs are being carried out to promote the adoption of cutting-edge molecular farming technologies and consequently increase productivity.
Recent Developments:
- In April 2022, Satellite Bio introduced a unique method for bioengineering tissues. This company has expertise in synthetic biology, regenerative medicine, cell therapy, cell biology, and tissue engineering.
Molecular Pharming Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 457.7 Mn |
|
Revenue Forecast In 2031 |
USD 1.399.8 Mn |
|
Growth Rate CAGR |
CAGR of 15.3 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Crop Type, Technology, Applications And End Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Leaf Expression Systems, ORF Genetics hf., Agrenvec S.L., PlantForm, Protalix Biotherapeutics, Kbio, Inc., Cape Biologix Technologies (Cape Bio Pharms), Bright Biotech, Moolec Science SA, Miruku, Tiamat Sciences Corp., IngredientWerks, Core Biogenesis, Diamante Società Benefit S.r.l., Elo Life Systems, G+FLAS Life Sciences, Inc., BIOBETTER, MOZZA FOODS, FORTE PROTEIN INC., KYOMEI, NOBELL FOODS, PIGMENTUM, MNPHARM, Finally Foods, Tiamat Sciences, POLOPO Ltd., VELOZBIO, newmoo Foods, BionFarming GmbH and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
